Integral Health Asset Management, LLC — 13F Holdings & Portfolio
CIK 1773206 · latest 13F-HR filed 2026-08-14
Integral Health Asset Management, LLC manages $2.53B in 13F-reported U.S. long-equity assets across 92 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are RVMD (11.10%), INSM (6.74%), CYTK (5.38%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 29 new positions and exited 26; 39 existing positions rose in reported value and 16 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-08-14
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
Portfolio map
Q2 26Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.
Sector mix
% of 13F valueSectors from each company's SIC code; funds and ETFs grouped separately.
Biggest buys and sells
Q1 26 → Q2 26Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.
13F assets and positions
4 quartersTotal reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.
Top positions over time
reported valueThe eight largest current positions, valued at each quarter end.
Concentration
top 10 = 46.5%Cumulative share of the portfolio held in the largest N positions.
As of the firm’s regulatory filing dated Mar 26, 2026.
| Name | Title / Status | Ownership | Type |
|---|---|---|---|
| DEL VIRGINIA, JOHN Control | CHIEF COMPLIANCE OFFICER & CHIEF OPERATING OFFICER since Sep 2021 | Less than 5% | Individual |
| INTEGRAL HEALTH ADVISORS, LP Control | LIMITED PARTNER since Sep 2022 | 75% or more | Domestic Entity |
| Rao, Bhagwan Jay Control | CHIEF INVESTMENT OFFICER since Feb 2019 | Less than 5% | Individual |
| INTEGRAL HEALTH ADVISORS GP, LLC Control Indirect owner via INTEGRAL HEALTH ADVISORS, LP | GENERAL PARTNER since Sep 2022 | General partner, trustee or manager | Domestic Entity |
| Rao, Bhagwan Jay Control Indirect owner via INTEGRAL HEALTH ADVISORS, LP | MANAGING MEMBER since Sep 2022 | 75% or more | Individual |
Ownership & leadership changes · 5 filings with changes since May 24, 2019
From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.
- No longer listedCHOU, TIMOTHY, W · SENIOR ANALYST · General partner, trustee or manager · indirect via INTEGRAL HEALTH ADVISORS, LP · listed since Sep 2022
- No longer listedDEL VIRGINIA, JOHN · CHIEF OPERATING OFFICER/CHIEF COMPLIANCE OFFICER · General partner, trustee or manager · indirect via INTEGRAL HEALTH ADVISORS, LP · control person · listed since Sep 2022
- No longer listedFishman, Cybele · MEMBER · 50–75% · indirect via INTEGRAL HEALTH ADVISORS GP, LLC · listed since Sep 2022
- No longer listedRao, Bhagwan Jay · MANAGING MEMBER · 50–75% · indirect via INTEGRAL HEALTH ADVISORS GP, LLC · control person · listed since Sep 2022
- No longer listedVirgilio, Alex, Adam · SENIOR ANALYST · General partner, trustee or manager · indirect via INTEGRAL HEALTH ADVISORS, LP · listed since Apr 2023
- No longer listedSTEPHANO, PAUL, ANTHONY · SENIOR ANALYST · General partner, trustee or manager · indirect via INTEGRAL HEALTH ADVISORS, LP · listed since Sep 2022
- AddedVirgilio, Alex, Adam · SENIOR ANALYST · General partner, trustee or manager · indirect via INTEGRAL HEALTH ADVISORS, LP
- AddedCHOU, TIMOTHY, W · SENIOR ANALYST · General partner, trustee or manager · indirect via INTEGRAL HEALTH ADVISORS, LP
- AddedDEL VIRGINIA, JOHN · CHIEF OPERATING OFFICER/CHIEF COMPLIANCE OFFICER · General partner, trustee or manager · indirect via INTEGRAL HEALTH ADVISORS, LP · control person
- AddedFishman, Cybele · MEMBER · 50–75% · indirect via INTEGRAL HEALTH ADVISORS GP, LLC
- AddedINTEGRAL HEALTH ADVISORS GP, LLC · GENERAL PARTNER · General partner, trustee or manager · indirect via INTEGRAL HEALTH ADVISORS, LP · control person
- AddedINTEGRAL HEALTH ADVISORS, LP · LIMITED PARTNER · 75% or more · control person
- AddedRao, Bhagwan Jay · MANAGING MEMBER · 75% or more · indirect via INTEGRAL HEALTH ADVISORS, LP · control person
- AddedRao, Bhagwan Jay · MANAGING MEMBER · 50–75% · indirect via INTEGRAL HEALTH ADVISORS GP, LLC · control person
- AddedSTEPHANO, PAUL, ANTHONY · SENIOR ANALYST · General partner, trustee or manager · indirect via INTEGRAL HEALTH ADVISORS, LP
- ChangedDEL VIRGINIA, JOHN · now a control person
- ChangedRao, Bhagwan Jay · title SOLE MEMBER → CHIEF INVESTMENT OFFICER; ownership 75% or more → Less than 5%
- AddedDEL VIRGINIA, JOHN · CHIEF COMPLIANCE OFFICER & CHIEF OPERATING OFFICER · Less than 5%
- ChangedRao, Bhagwan Jay · title CHIEF COMPLIANCE OFFICER, SOLE MEMBER → SOLE MEMBER
- ChangedRao, Bhagwan Jay · title SOLE MEMBER → CHIEF COMPLIANCE OFFICER, SOLE MEMBER
- ListedRao, Bhagwan Jay · SOLE MEMBER · 75% or more · control person
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- REVOLUTION MEDICINES INC$135.0M +92.6%
- CVS HEALTH CORP$103.0M +956.3%
- AXSOME THERAPEUTICS INC.$67.5M +1141.3%
- EDWARDS LIFESCIENCES CORP$42.9M +315.3%
- EDGEWISE THERAPEUTICS INC$30.9M +61.2%
Top Trims
- INSMED INC-$74.7M -30.5%
- REGENERON PHARMACEUTICALS-$40.7M -62.0%
- BRIGHTSPRING HEALTH SVCS INC-$14.9M -28.0%
- MINERALYS THERAPEUTICS INC-$8.2M -40.2%
- NOVARTIS AG-$6.8M -17.9%
New Positions
- ABBOTT LABORATORIES$36.3M
- UNITEDHEALTH GROUP INC$35.3M
- TENET HEALTHCARE CORP$30.9M
- SPYRE THERAPEUTICS INC$28.9M
- NOVO-NORDISK A S$28.8M
Exited Positions
- ASTRAZENECA PLC$49.3M
- ASCENDIS PHARMA A/S$26.3M
- FRESENIUS MEDICAL CARE AG$17.5M
- INTUITIVE SURGICAL INC$16.1M
- TARSUS PHARMACEUTICALS INC$14.0M
Integral Health Asset Management, LLC Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | REVOLUTION MEDICINES INC | RVMD | 76155X100 | $280.9M | 11.10% | 1,500,000 | SH |
| 2 | INSMED INC | INSM | 457669307 | $170.6M | 6.74% | 1,600,000 | SH |
| 3 | CYTOKINETICS INC | CYTK | 23282W605 | $136.3M | 5.38% | 1,600,000 | SH |
| 4 | CVS HEALTH CORP | CVS | 126650100 | $113.8M | 4.49% | 1,100,000 | SH |
| 5 | EDGEWISE THERAPEUTICS INC | EWTX | 28036F105 | $81.3M | 3.21% | 2,000,000 | SH |
| 6 | VERA THERAPEUTICS INC | VERA | 92337R101 | $75.1M | 2.97% | 1,750,000 | SH |
| 7 | AXSOME THERAPEUTICS INC. | AXSM | 05464T104 | $73.4M | 2.90% | 300,000 | SH |
| 8 | CARDINAL HEALTH INC | CAH | 14149Y108 | $71.3M | 2.81% | 300,000 | SH |
| 9 | ROIVANT SCIENCES LTD | ROIV | G76279101 | $70.8M | 2.80% | 2,000,000 | SH |
| 10 | RHYTHM PHARMACEUTICALS INC | RYTM | 76243J105 | $61.1M | 2.41% | 550,000 | SH |
| 11 | EDWARDS LIFESCIENCES CORP | EW | 28176E108 | $56.5M | 2.23% | 625,000 | SH |
| 12 | REVOLUTION MEDICINES INC Put | RVMD | 76155X100 | $56.2M | 2.22% | 300,000 | SH |
| 13 | ALIGNMENT HEALTHCARE INC | ALHC | 01625V104 | $47.6M | 1.88% | 2,000,000 | SH |
| 14 | MERCK & CO INC | MRK | 58933Y105 | $45.0M | 1.78% | 350,000 | SH |
| 15 | QUEST DIAGNOSTICS INC | DGX | 74834L100 | $42.4M | 1.67% | 200,000 | SH |
| 16 | UNIQURE NV | QURE | N90064101 | $41.5M | 1.64% | 900,000 | SH |
| 17 | SCHOLAR ROCK HLDG CORP | SRRK | 80706P103 | $41.2M | 1.63% | 750,000 | SH |
| 18 | BOSTON SCIENTIFIC CORP | BSX | 101137107 | $38.4M | 1.52% | 900,000 | SH |
| 19 | BRIGHTSPRING HEALTH SVCS INC | BTSG | 10950A106 | $38.4M | 1.52% | 550,000 | SH |
| 20 | ABBOTT LABORATORIES | ABT | 002824100 | $36.3M | 1.43% | 400,000 | SH |
| 21 | UNITEDHEALTH GROUP INC | UNH | 91324P102 | $35.3M | 1.40% | 85,000 | SH |
| 22 | LIFESTANCE HEALTH GROUP INC | LFST | 53228F101 | $32.1M | 1.27% | 3,000,000 | SH |
| 23 | NOVARTIS AG | NVS | 66987V109 | $31.3M | 1.24% | 200,000 | SH |
| 24 | TANGO THERAPEUTICS INC | TNGX | 87583X109 | $31.3M | 1.23% | 1,000,000 | SH |
| 25 | TENET HEALTHCARE CORP | THC | 88033G407 | $30.9M | 1.22% | 165,000 | SH |
| 26 | SPYRE THERAPEUTICS INC | SYRE | 00773J202 | $28.9M | 1.14% | 325,000 | SH |
| 27 | NOVO-NORDISK A S | NVO | 670100205 | $28.8M | 1.14% | 600,000 | SH |
| 28 | DEFINIUM THERAPEUTICS INC | DFTX | 24477V105 | $25.9M | 1.02% | 550,000 | SH |
| 29 | NEUROCRINE BIOSCIENCES INC | NBIX | 64125C109 | $25.3M | 1.00% | 150,000 | SH |
| 30 | REGENERON PHARMACEUTICALS | REGN | 75886F107 | $24.9M | 0.99% | 40,000 | SH |
| 31 | IONIS PHARMACEUTICALS INC Call | IONS | 462222100 | $23.8M | 0.94% | 300,000 | SH |
| 32 | BIOGEN INC | BIIB | 09062X103 | $21.6M | 0.85% | 100,000 | SH |
| 33 | TRAVERE THERAPEUTICS INC | TVTX | 89422G107 | $21.3M | 0.84% | 375,000 | SH |
| 34 | LANTHEUS HLDGS INC | LNTH | 516544103 | $21.1M | 0.83% | 190,000 | SH |
| 35 | GLAUKOS CORP | GKOS | 377322102 | $21.0M | 0.83% | 150,000 | SH |
| 36 | ORIC PHARMACEUTICALS INC | ORIC | 68622P109 | $20.6M | 0.81% | 1,900,000 | SH |
| 37 | BRIDGEBIO PHARMA INC | BBIO | 10806X102 | $20.5M | 0.81% | 275,000 | SH |
| 38 | VERTEX PHARMACEUTICALS INC | VRTX | 92532F100 | $19.9M | 0.78% | 40,000 | SH |
| 39 | ALUMIS INC | ALMS | 022307102 | $19.7M | 0.78% | 700,000 | SH |
| 40 | ELEVANCE HEALTH INC FORMERLY | ELV | 036752103 | $19.3M | 0.76% | 50,000 | SH |
| 41 | CENTENE CORP DEL | CNC | 15135B101 | $19.3M | 0.76% | 300,000 | SH |
| 42 | ERASCA INC | ERAS | 29479A108 | $18.3M | 0.72% | 1,000,000 | SH |
| 43 | ELI LILLY & CO | LLY | 532457108 | $18.0M | 0.71% | 15,000 | SH |
| 44 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 04280A100 | $16.3M | 0.64% | 200,000 | SH |
| 45 | ENVISTA HOLDINGS CORPORATION | NVST | 29415F104 | $15.8M | 0.62% | 600,000 | SH |
| 46 | MEDTRONIC PLC | MDT | G5960L103 | $15.6M | 0.62% | 200,000 | SH |
| 47 | WATERS CORP | WAT | 941848103 | $15.0M | 0.59% | 40,000 | SH |
| 48 | LIVANOVA PLC | LIVN | G5509L101 | $14.8M | 0.58% | 180,000 | SH |
| 49 | NOVO-NORDISK A S Call | NVO | 670100205 | $14.4M | 0.57% | 300,000 | SH |
| 50 | FORTE BIOSCIENCES INC | FBRX | 34962G208 | $14.3M | 0.57% | 675,000 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $2.53B | 92 | 0001172661-26-003449 |
| 2026-03-31 | 2026-05-15 | $2.09B | 90 | 0001172661-26-002081 |
| 2025-12-31 | 2026-02-17 | $2.01B | 86 | 0001172661-26-000915 |
| 2025-09-30 | 2025-11-14 | $1.48B | 76 | 0001172661-25-004839 |
19TH FLOOR
NEW YORK, NY 10022